Gastrointestinal cancer Clinical Trials
Recruiting gastrointestinal cancer studies with sites across the US, sourced from ClinicalTrials.gov and refreshed daily. Free to join — find one near you below.
Clinical trials study new ways to prevent, detect, or treat gastrointestinal cancer. Joining one can give you access to investigational treatments and close monitoring by a specialist research team — at no cost — while helping advance care for others. Below are recruiting gastrointestinal cancer studies with sites across the US; use the location tools to find ones near you.
What to expect
- Screening first. The study team reviews your eligibility before anything else — there's no obligation to continue.
- Informed consent. You'll get a full explanation of the study, its potential risks and benefits, and can withdraw at any time.
- No cost to you. Study visits, tests, and the investigational treatment are covered; many studies reimburse travel.
Recruiting gastrointestinal cancer trials
A Study of Selective Internal Radiation Therapy for the Management of Chemotherapy-induced Thrombocytopenia With Splenomegaly in Adult Subjects With Gastrointestinal Cancer
EAT-ING: Enhancing Anticancer Treatment Safety Via Immunomodulatory Nutritional Support in Advanced Gastrointestinal Cancers
Digitally Supported Prehabilitation Before Major Visceral Cancer Surgery
Non-Operative Management and Following Immunotherapy for Colorectal Cancer and Other GI Cancers
Food-related Quality of Life in Patients With Cancer
Study of High-Precision Evaluation of Molecular ResiduaL Disease Through a PlatfOrm for Cancer TracKing and Interception (SHERLOCK)
Safety, Tolerance and Preliminary Efficacy of XH001 Injection Combined With Neoantigen Vaccine-induced Tumor-specific T-cell Injection in Advanced Gastrointestinal Cancer
DETERMINE Trial Treatment Arm 07: Dabrafenib in Combination With Trametinib in Adult, Paediatric and Teenage/Young Adult Patients With BRAF V600 Mutation-Positive Cancers.
A Study of DB-1324 in Advanced/Metastatic Gastrointestinal Tumors
Intraoperative Imaging of Gastrointestinal Malignancies Using Pafolacianine (CYTALUX™)
Hyperthermia Combined With Immune Checkpoint Inhibitors in the Treatment of Advanced Gastrointestinal Malignancies With Liver Metastases
Evaluating Microarray Pharmacogenetic Testing in Cancer Patients
Postbiotics for Mitigation of Postoperative Dysbiosis in Gastrointestinal Cancer Surgery
BOLSTER: Learning New Skills to Thrive
Total Neoadjuvant FLOT Chemotherapy in Locally Advanced Gastric and Gastroesophageal Junction Cancer
Evaluation of the Preliminary Efficacy and Safety of DR30206 in Combination With Standard Therapy in Patients With Gastrointestinal Cancer
Extracellular Vesicles and Chemotherapy-Induced Peripheral Neuropathy
Fatigue and Molecular Mechanisms in Cancer Patients Receiving CCRT
Palliative Radiotherapy in Symptomatic Pelvic Soft Tissue Tumors
EQUITY GI: A Prospective Study to Enhance Quality, Inclusivity, and Trial Participation in Black Patients With Gastrointestinal Cancer.
Sacituzumab Govitecan in Combination With Capecitabine for Advanced Gastrointestinal Cancers After Progression on Standard Therapy
PhI Pilot Study Pafolacianine Inject for Intraoperative Imaging on Outcomes of GI Cancer Peritoneal Carcinomatosis
Study of Patritumab Deruxtecan in Participants With Gastrointestinal Cancers (MK-1022-011) (HERTHENA-PanTumor02)
Dyadic Sleep Study
Safety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple Myeloma
REmote Symptom COllection to improVE postopeRative Care
A Study of GC203 TIL in Advanced Malignant Solid Tumors
Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors
Goals of Care Discussion for Patients With Advanced Lung and Gastrointestinal Cancer in the Emergency Department of a Comprehensive Cancer Center
EUS Examination Using EndoSound Vision System vs. Standard Echoendoscope
BGT007 Cells for the Treatment of Refractory Digestive System Tumors
JUMP_START - Optimization of Care for Young Cancer Patients with Gastrointestinal Tumors
A Study of Radiation Therapy to Treat Solid Tumor Cancer That Has Spread to Soft Tissue
Prospective Procurement of Tumor Tissue to Identify Novel Therapeutic Targets and Study the Tumor Microenvironment
A Study on the Effects of Exercise on Side Effects From Treatment for Gastrointestinal Cancers
SURGE: Supporting UnderRepresented Minorities in Genomics-based Cancer Trial Enrollment (Intervention)
Disease Outcomes and Toxicities in Patients With Gastrointestinal and Sarcomatous Malignancies
Frailty in Patients With Gastrointestinal Cancer Who Are Undergoing Major Surgery
Quality of Care in Relationship to Aborted Cancer Surgery
Optimizing and Personalising Azacitidine Combination Therapy for Treating Solid Tumours QPOP and CURATE.AI
Pemigatinib in the Advanced Gastrointestinal Cancer With FGFR 1-3 Alterations
PSMA in Gastroenterologic Tumors (GIPSMA)
Neratinib and Fam-Trastuzumab Deruxtecan in Advanced Gastro-esophageal Cancer Patients
Improving Comprehensive Care of Cancer Patients
Resilience and Equity in Aging, Cancer, and Health (REACH)
Individual Response to Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Treatment of Peritoneal Carcinomatosis From Peritoneal Mesothelioma or Atypical Mesothelial Proliferation or From Ovarian, Colorectal, or Appendiceal Histologies
Stereotactic Brain-directed Radiation With or Without Aguix Gadolinium-Based Nanoparticles in Brain Metastases
Electroporation for Cancer Treatment Real World Registry
EUS Guided HVA and PVA for Circulating Tumor DNA in Patients
Investigating the Effects of Atezolizumab in People Whose Tumour DNA or RNA Indicates Possible Sensitivity
Circulating Tumor DNA (ctDNA) for Early Treatment Response Assessment of Solid Tumors
OH2 Oncolytic Viral Therapy in Solid Tumors
Administering Peripheral Blood Lymphocytes Transduced With a Murine T-Cell Receptor Recognizing the G12V Variant of Mutated RAS in HLA-A*11:01 Patients
Ontario-wide Cancer TArgeted Nucleic Acid Evaluation
Immunobiology Blood and Tissue Collection of Upper Aerodigestive Malignancies
Acquisition of Blood and Tumor Tissue Samples From Patients With Gastrointestinal Cancer
Harvesting Cells for Experimental Cancer Treatments
Gastrointestinal cancer clinical trials — common questions
Are gastrointestinal cancer clinical trials free to join?
Yes. Participating in a gastrointestinal cancer clinical trial is free — study-related visits, tests, and the investigational treatment are provided at no cost to you. Many studies also reimburse travel and time. You never pay to take part.
Who can join a gastrointestinal cancer clinical trial?
Each gastrointestinal cancer study sets its own eligibility criteria — typically based on age, medical history, current treatments, and overall health. Every trial listed here shows its criteria, and the study team confirms your eligibility before enrollment. You can review and apply to any that look like a fit.
How do I find a gastrointestinal cancer trial near me?
Use the location controls above. We'll show recruiting gastrointestinal cancer trials with sites near you, sorted by distance. You can widen the radius or share your exact location for the closest matches.
How many gastrointestinal cancer trials are recruiting right now?
We're currently tracking roughly 32 recruiting gastrointestinal cancer trials with US sites, sourced from ClinicalTrials.gov and refreshed daily.
Looking for a specific location? Browse trials by city and state.